Search results
Pioneer Institute study finds IRA discourages non-opioid drug innovation
Pharmaceutical Technology via Yahoo Finance· 3 days agoMovement in the non-opioid pain drug space Still, some updates continue to happen in the the pain...
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
Reuters· 4 days agoRegeneron Pharmaceuticals and Mammoth Biosciences will collaborate to research, develop and...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AIRC, ALPN, WIRE
The Bradford Era· 6 days agoNEW YORK, April 23, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 7 days agoNEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are
9 Stocks That Thrive When Interest Rates Are Higher
Barrons.com· 4 days agoConsumer staples, utilities, and healthcare sectors tend to do jhold up better than most when financial conditions tighten. Some standout stocks with...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 4 days agoBiotech Stock Nabs Takeover Deal Alpine Immune Sciences is working on treatments for inflammatory...
Gene Therapy Trial for Sickle Cell Disease Publishes Final Results
Technology Networks· 4 days agoIn a landmark study, an international consortium led by researchers at Children’s Hospital of...
Op-ed: Here are 6 health-care stocks to watch now, amid a bumpy recovery
CNBC· 5 days agoHealth care, long an ailing stock market sector, has recovered over the past six months, with...
Profluent combines LLMs and CRISPR for open-source gene editing project
FierceBiotech· 6 days agoThe protein-focused artificial intelligence startup believes that its large language models can help extend the reach of CRISPR gene editing tools in the development of new therapies—and to ...
Edgewise gets EU orphan drug status for muscular dystrophy drug (NASDAQ:EWTX)
Seeking Alpha· 6 days agoEdgewise Therapeutics (EWTX) has received orphan drug designation from EU regulators for sevasemten...
